HOME >> BIOLOGY >> NEWS
Hopes raised for effectiveness of multiple sclerosis drug

Discovery of the mechanism of a drug being tested for the treatment of multiple sclerosis (MS) has revealed that it's not only more effective than first thought, but might also help in the management of other autoimmune diseases, organ transplant rejection and even cancer.

A research team led by the University of Cincinnati's Bibiana Bielekova, MD, report new insights into the role of the MS drug daclizumab (Zenapax) in the March 27 online version of the Proceedings of the National Academy of Sciences. The article will appear in print April 11.

The exact cause of MS is unknown, but one theory is that it may it be triggered by exposure to a viral infection or environmental influences. The disease takes different courses in different people and can go into remission for many years, recurring occasionally or progressing quickly into degeneration of all motor functions that control muscles, strength, vision and balance. The very progressive form of the disease can end in death.

Scientists have long thought that in MS the specific white cells (T-cells) that fight off infection actually turn on the body they are supposed to protect, attacking the myelin sheath that protects the nerves.

"Without the insulating cover, the nerve axons short-circuit, much like a damaged electric cord might," says Dr. Bielekova, director of UC's Waddell Center for Multiple Sclerosis. "Also, many nerve cells (neurons) do not survive without myelin sheath."

It was also believed that since activated T-cells need a growth factor called interleukin 2 for their function, drugs that can block the interaction of interleukin-2 and T-cells could be used to control MS.

Daclizumab is being tested against MS because it has already proved useful in preventing rejection of transplanted organs, "and we thought it works by inhibiting T-cell activation," Bielekova says.

Earlier research by Dr. Bielekova and her group showed that daclizumab benefits MS p
'"/>

Contact: Sheryl Hilton
sheryl.hilton@uc.edu
513-558-4561
University of Cincinnati
28-Mar-2006


Page: 1 2 3

Related biology news :

1. Aquatic scientist praised for holistic research
2. New Accutane controls praised by March of Dimes
3. Studies assess effectiveness of serotonin and nerve stimulants on irritable bowel syndromes
4. Nitric oxide: Key to cardiovascular and pulmonary function and drug effectiveness
5. First systematic study of Chinas one-child policy reveals complexity, effectiveness
6. Protein identified that regulates effectiveness of Taxol chemotherapy in breast cancer
7. New biomarker predicts effectiveness of breast cancer drugs
8. Test reveals effectiveness of potential Huntingtons disease drugs
9. Genetic variation impacts aspirins effectiveness in preventing colon cancer, Dartmouth study finds
10. Cost-effectiveness study of three antimalarial drug combinations in Tanzania
11. Potential diagnostic marker indicates effectiveness of anti-angiogenic drugs

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/23/2018)... ... ... have hosted a variety of groups this year – both new guests and those returning ... and more, have all visited the La Jolla-based venue time and time again as a ... is due to Lajollacooks4u’s signature team-building format, a way for teams to not only interact ...
(Date:8/21/2018)... MADISON, Wis. (PRWEB) , ... August 21, 2018 ... ... of high throughput screening (HTS) solutions, Bellbrook Labs is dedicated to offering customers ... regarding biochemical assays, visitors will find a seamless transition between products, with relevant ...
(Date:8/17/2018)... CASTLE ROCK, Colo. (PRWEB) , ... August 16, 2018 , ... ... for facioscapulohumeral muscular dystrophy (FSHD), announced that its Colorado Chapter will be holding its ... event, scheduled for September 8th at the Philip S. Miller Park, advocates for public ...
Breaking Biology News(10 mins):
(Date:9/12/2018)... Wash. (PRWEB) , ... September 11, 2018 , ... ... is proud to add flat sheet Forward Osmosis (FO) membranes from Fluid Technology ... FO membranes manufactured by FTS H2O are constructed from cellulose triacetate (CTA) material. ...
(Date:9/7/2018)... ... September 06, 2018 , ... ... September 25th-28th is a meeting of “The industry’s preeminent event on novel drug ... discovery scientists powerful tools to study these emerging targets in a quest to ...
(Date:9/7/2018)... ANN ARBOR, Mich. (PRWEB) , ... September 06, 2018 , ... ... of Directors. Dunbar has spent his career as an executive and leader of numerous ... Biologics, a private cell therapy and biologics company acquired by Thompson Street Capital in ...
(Date:8/31/2018)... ... August 30, 2018 , ... Small, wireless and networked describes more than the ... connected, too. Draper’s latest system is tiny in size, but is poised to make ... in the new implant design is the growing awareness that disease often involves complex ...
Breaking Biology Technology:
Cached News: